www.hivandhepatitis.com

Skip to content

Top 10 HIV and Hepatitis Stories of 2017

For our last issue, HIVandHepatitis.com reviews some the year's major HIV, viral hepatitis, and related news highlights. As we enter 2018, antiretroviral treatment for HIV is about as good as it can get, use of PrEP for HIV prevention is expanding rapidly, and most people can be cured of hepatitis C with 2 or 3 months of well-tolerated therapy. But these advances are still not reaching everyone who needs them. The search for a functional cure for HIV, better treatments for hepatitis B, and m...

A Message To Our Readers

California Supervised Injection Bill Stalls, but San Francisco Moves Forward

San Francisco Getting to Zero Update Hears U=U Message

EACS 2017: How a London Clinic Reduced New HIV Infections by 90%

EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines

EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort

AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use

AASLD 2017: Immune Modulator Inarigivir Looks Promising for Hepatitis B

AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study

Back Home

Coverage of the 2017 EASL International Liver Conference

HIVandHepatitis.com coverage of the 2017 International Liver Congress, annual meeting of the European Society for the Study of the Liver (EASL), April 19-23, 2017, in Amsterdam

Full coverage listing by topic

International Liver Congress website

4/30/17

alt

Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com coverage of the 2017 Conference on Retroviruses and Opportunistic infections (CROI 2017), February 13-16, 2017, in Seattle.

Full coverage listing by topic

CROI website

4/16/17

alt

A Message To Our Readers

As of the new year, HIVandHepatitis.com will be transferred to Smart + Strong, the publisher of POZ, Hep, Real Health, and the new Cancer Health magazines and websites. HIVandHepatitis.com will remain online as an archive for the near future but will not publish new content. HIVandHepatitis.com editor Liz Highleyman is now editor-in-chief of Cancer Health.

alt

California Supervised Injection Bill Stalls, but San Francisco Moves Forward

San Francisco would be best served by having several supervised injection sites accompanied by social services for people who use drugs, according to a report from a city task force set up to study the issue.

alt

	The Liver Meeting (AASLD 2017) October 20-24, 2017, Washington, DC
	6th European AIDS Conference (EACS 2017) October 20-27, 2017, Milan
	9th IAS Conference on HIV Science (IAS 2017) July 23-26, 2017, Paris
	2017 Harm Reduction International Conference May 14-17, 2017, Montreal
	2017 Pediatric Academic Societies Meeting May 6-9, 2017, San Francisco
	2017 EASL International Liver Congress April 19-23, 2017, Amsterdam
	2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) February 13-16, 2017, Seattle
	The Liver Meeting (AASLD 2016) November 11-15, 2016, Boston
	IDWeek 2016 October 26-30, 2016, New Orleans
	HIV Drug Therapy 2016 October 23-26, 2016, Glasgow
	HIV Research for Prevention (HIVR4P 2016) October 17-21, 2016, Chicago
	5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) Sept 7-9, 2016, Oslo
	21st International AIDS Conference (AIDS 2016) July 18-22, 2016, Durban
	ASM Microbe 2016/ICAAC 2016 June 16-20, 2016, Boston
	2016 EASL International Liver Congress April 13-17, 2016, Barcelona
	2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016) February 22-25, 2016, Boston
	2015 National HIV Prevention Conference (NHPC 2015) December 6-9, 2015, Atlanta
	46th Union World Conference on Lung Health December 2-6, 2015, Cape Town
	The Liver Meeting (AASLD 2015) November 13-17, 2015, San Francisco
	15th European AIDS Conference (EACS 2015) October 21-24, 2015, Barcelona
	24th International Harm Reduction Conference (IHRC 2015) October 18-21, 2015, Kuala Lumpur
	IDWeek 2015 October 7-11, 2015, San Diego
	4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015) October 7-9, 2015, Sydney
	55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2015) September 17-21, 2015, San Diego
	8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2015) July 19-22, 2015, Vancouver
	Digestive Disease Week 2015 May 16-19, 2015, Washington, DC
	50th International Liver Congress (EASL 2015) April 22-26, 2015, Vienna
	21st Annual Meeting of the British HIV Association (BHIVA) April 21-24, 2015, Brighton
	2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015) February 23-26, 2015, Seattle

www.hivandhepatitis.com

Syndicate Feeds

Top 10 HIV and Hepatitis Stories of 2017

HIV Cure Summit Hears About New Remission Case

Coverage of the 2017 AASLD Liver Meeting

Coverage of the 2017 IAS Conference on HIV Science

Coverage of the 2017 EASL International Liver Conference

Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections

A Message To Our Readers

California Supervised Injection Bill Stalls, but San Francisco Moves Forward

San Francisco Getting to Zero Update Hears U=U Message

EACS 2017: How a London Clinic Reduced New HIV Infections by 90%

EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines

EACS 2017: Test-and-Treat Reduces HCV Among Gay Men in Swiss HIV Cohort

AASLD 2017: Hepatitis C Testing Linked to Reduced Opioid Use

AASLD 2017: Immune Modulator Inarigivir Looks Promising for Hepatitis B

AASLD 2017: Nivolumab Improves Outcomes in Liver Cancer Study

Coverage of the 2017 EASL International Liver Conference

Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections

A Message To Our Readers

California Supervised Injection Bill Stalls, but San Francisco Moves Forward

CONFERENCE COVERAGE